DEEP TRACK CAPITAL, LP
DEEP TRACK CAPITAL, LP runs DEEP TRACK CAPITAL, LP and currently holds 67 stock positions, which is fewer than the average of 230 among the investors we track. The portfolio is valued at approximately $6.87B. Their top holdings are GH, IMVT, PCVX, ALNY, MANE. The top five represent 23.5% of reported portfolio weight. DEEP TRACK CAPITAL, LP ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, DEEP TRACK CAPITAL, LP initiated 13 new positions. They added to 19 existing positions. They trimmed 11 positions. Their current best-performing preview position is CMPS with returns of +155.88%.
67 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
GH GUARDANT HEALTH INC | 7.41% | $40.05 | $170.69 | +326.19% | Added +1.65% |
IMVT IMMUNOVANT INC | 5.24% | $22.63 | $44.37 | +96.07% | Trimmed -18.96% |
PCVX VAXCYTE INC | 3.64% | $39.08 | $62.62 | +60.24% | Held |
ALNY ALNYLAM PHARMACEUTICALS INC | 3.61% | $301.03 | $236.22 | -21.53% | New Buy |
MANE VERADERMICS INC | 3.58% | $107.99 | $102.97 | -4.65% | Added +300.00% |
TARS TARSUS PHARMACEUTICALS INC | 3.36% | $56.63 | $72.70 | +28.38% | Added +1.85% |
NUVL NUVALENT INC | 3.21% | $107.25 | $123.96 | +15.58% | Added +29.57% |
ALKS ALKERMES PLC | 3.05% | $33.42 | $48.33 | +44.61% | Added +11.41% |
OCUL OCULAR THERAPEUTIX INC | 2.81% | $7.38 | $11.08 | +50.14% | Held |
BMRN BIOMARIN PHARMACEUTICAL INC | 2.75% | $57.97 | $66.70 | +15.06% | Added +187.61% |
Showing 1-10 of 67